Scientist Stories: David MacMillan, New Chemical Reactions & Developing Asymmetric Organocatalysis

4 Jan 2023 · 33 min
32:36

In this lecture, Nobel laureate David MacMillan explains the concept of asymmetric organocatalysis, tracing its origins, development, and impact. He begins by defining catalysis and asymmetry in accessible terms, illustrating how catalytic processes underpin modern society—from ammonia synthesis that feeds billions to the majority of industrial chemical production. He then describes the historical landscape of asymmetric catalysis in the mid‑1990s, highlighting the limitations of metal‑based systems and the promise of purely organic catalysts. Drawing on his own career path—from a PhD at UC Irvine, post‑doctoral work with Larry Overman and David Evans, to his independent group at Berkeley—MacMillan recounts the pivotal insight that iminium ion formation could be harnessed by small organic molecules. He details the discovery of the first organocatalytic Diels‑Alder reaction, the iterative optimization of imidazolinone catalysts to achieve >90 % enantiomeric excess, and the broader strategy of a “generic activation mode” that could be applied to many reaction classes. The talk covers subsequent generations of catalysts, the expansion into enamine, phase‑transfer, Lewis‑base, carbene, and hydrogen‑bonding organocatalysis, and the collaborative work that enriched the field. MacMillan then explores merging organocatalysis with radical chemistry (SOMO‑catalysis) and photoredox catalysis, illustrating how visible‑light activation creates new bond‑forming possibilities. Real‑world applications are highlighted: fragrance synthesis at Firmenich, recyclable‑plastic depolymerization, and the production of the migraine drug talcedupan. He emphasizes the democratizing nature of organocatalysis—its low cost, ease of handling, and global accessibility—arguing that future breakthroughs will come from any corner of the world. Finally, he reflects on the sustainable future of catalysis, the importance of interdisciplinary approaches, and offers heartfelt acknowledgments to mentors, collaborators, family, and those who inspired his journey.

Chapters

More from Joshua

youtube.com

Scientist Stories: Jennifer Doudna, The Code Breaker

10mo ago
youtube.com

Founder Stories: Helmy Eltoukhy, Founder & CEO of Guardant Health

1y ago
youtube.com

Scientist Stories: Fabian Theis, Machine Learning and Systems Biology

2y ago
youtube.com

Scientist Stories: Thomas Lanyon-Hogg, Chemical Biology in Drug Discovery

2y ago
youtube.com

Founder Stories: Bobby Gaspar, Manufacturing Hematopoietic Stem Cells

2y ago
youtube.com

Scientist Stories: Dana Pe'er, Single-Cell Gene Regulation

2y ago
youtube.com

Scientist Stories: Hans Waterham, The value of phenotypic assays in peroxisomal disorders

2y ago
youtube.com

Scientist Stories: Michael Rosenblum, Exploring Regulatory T-Cells

2y ago
youtube.com

Scientist Stories: Hannah Mitchison, Expanding Ciliopathies

2y ago
youtube.com

Scientist Stories: Leonardo Ferreira, Engineered Immune Cell Therapies

2y ago
youtube.com

Scientist Stories: Joel Zlotogora, Genetic carrier screening programs for reproductive purposes

2y ago
See all content